Mostrar el registro sencillo del ítem

dc.contributor.author
Celi Castillo, Ana Beatriz  
dc.contributor.author
Goldstein Raij, Jorge  
dc.contributor.author
Rosato Siri, María Victoria  
dc.contributor.author
Vasconcelos Esteves Pinto, Alipio  
dc.date.available
2023-07-13T12:02:33Z  
dc.date.issued
2022-02  
dc.identifier.citation
Celi Castillo, Ana Beatriz; Goldstein Raij, Jorge; Rosato Siri, María Victoria; Vasconcelos Esteves Pinto, Alipio; Role of Globotriaosylceramide in Physiology and Pathology; Frontiers Media; Frontiers in Molecular Biosciences; 9; 2-2022; 1-20  
dc.identifier.issn
2296-889X  
dc.identifier.uri
http://hdl.handle.net/11336/203652  
dc.description.abstract
At first glance, the biological function of globoside (Gb) clusters appears to be that of glycosphingolipid (GSL) receptors for bacterial toxins that mediate host-pathogen interaction. Indeed, certain bacterial toxin families have been evolutionarily arranged so that they can enter eukaryotic cells through GSL receptors. A closer look reveals this molecular arrangement allocated on a variety of eukaryotic cell membranes, with its role revolving around physiological regulation and pathological processes. What makes Gb such a ubiquitous functional arrangement? Perhaps its peculiarity is underpinned by the molecular structure itself, the nature of Gb-bound ligands, or the intracellular trafficking unleashed by those ligands. Moreover, Gb biological conspicuousness may not lie on intrinsic properties or on its enzymatic synthesis/degradation pathways. The present review traverses these biological aspects, focusing mainly on globotriaosylceramide (Gb3), a GSL molecule present in cell membranes of distinct cell types, and proposes a wrap-up discussion with a phylogenetic view and the physiological and pathological functional alternatives.  
dc.format
application/pdf  
dc.language.iso
eng  
dc.publisher
Frontiers Media  
dc.rights
info:eu-repo/semantics/openAccess  
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/  
dc.subject
CANCER  
dc.subject
GB3  
dc.subject
GLYCOSPHINGOLIPID PATHOLOGY  
dc.subject
GLYCOSPHINGOLIPID PHYSIOLOGY  
dc.subject
GLYCOSPHINGOLIPIDS  
dc.subject
HEMOLYTIC UREMIC SYNDROME  
dc.subject.classification
Enfermedades Infecciosas  
dc.subject.classification
Ciencias de la Salud  
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD  
dc.title
Role of Globotriaosylceramide in Physiology and Pathology  
dc.type
info:eu-repo/semantics/article  
dc.type
info:ar-repo/semantics/artículo  
dc.type
info:eu-repo/semantics/publishedVersion  
dc.date.updated
2023-07-03T16:42:59Z  
dc.journal.volume
9  
dc.journal.pagination
1-20  
dc.journal.pais
Suiza  
dc.description.fil
Fil: Celi Castillo, Ana Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.description.fil
Fil: Goldstein Raij, Jorge. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.description.fil
Fil: Rosato Siri, María Victoria. Comisión Nacional de Energía Atómica. Centro Atómico Bariloche; Argentina. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina  
dc.description.fil
Fil: Vasconcelos Esteves Pinto, Alipio. Consejo Nacional de Investigaciones Científicas y Técnicas. Oficina de Coordinación Administrativa Houssay. Instituto de Fisiología y Biofísica Bernardo Houssay. Universidad de Buenos Aires. Facultad de Medicina. Instituto de Fisiología y Biofísica Bernardo Houssay; Argentina  
dc.journal.title
Frontiers in Molecular Biosciences  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http://dx.doi.org/10.3389/fmolb.2022.813637  
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/https://www.frontiersin.org/articles/10.3389/fmolb.2022.813637/full